For those of you who are super duper bored this beautiful Sunday morning….I have begun my annual posting of ASCO abstracts. My thoughts will always be in red…so that it is clear that they are merely mine…and points will be highlighted in red if I think they are particularly pertinent, otherwise they are the abstracts as they are. I will group them and plow through them as best I can. Blessings to all the ratties!!! Good luck to you all. celeste
I'm really hoping to see some data from this ASCO showing post treatment results for the Anti-PD1s. In other words is anyone recurring after stopping treatment and in what numbers. Inquiring minds want to know!
I'm really hoping to see some data from this ASCO showing post treatment results for the Anti-PD1s. In other words is anyone recurring after stopping treatment and in what numbers. Inquiring minds want to know!
I'm really hoping to see some data from this ASCO showing post treatment results for the Anti-PD1s. In other words is anyone recurring after stopping treatment and in what numbers. Inquiring minds want to know!
Hi Brian, I have a link to a video with Jeffrey Weber, Jason Luke and Keith Flaherty talking about duration of Immunotherapy from 2016 and they get into talking about recurring after stopping. I think that future trials and or treatments will have to be stuctured with specific end points to be able to get the data. Right now it is kind of based on how each Oncologist feels and not on science. Best wishes!!! Ed https://www.youtube.com/watch?v=aSXv02OdoO4
Hi Brian, I have a link to a video with Jeffrey Weber, Jason Luke and Keith Flaherty talking about duration of Immunotherapy from 2016 and they get into talking about recurring after stopping. I think that future trials and or treatments will have to be stuctured with specific end points to be able to get the data. Right now it is kind of based on how each Oncologist feels and not on science. Best wishes!!! Ed https://www.youtube.com/watch?v=aSXv02OdoO4
Hi Brian, I have a link to a video with Jeffrey Weber, Jason Luke and Keith Flaherty talking about duration of Immunotherapy from 2016 and they get into talking about recurring after stopping. I think that future trials and or treatments will have to be stuctured with specific end points to be able to get the data. Right now it is kind of based on how each Oncologist feels and not on science. Best wishes!!! Ed https://www.youtube.com/watch?v=aSXv02OdoO4
Thanks Ed. Good video. Dr. Weber is awesome. He's such a straight shooter. Comment of the chat, "Let's get data driven" as he begins to state his case.
I hope they can still accrue some data from the past and current trials even though the end points have varied.
Thanks Ed. Good video. Dr. Weber is awesome. He's such a straight shooter. Comment of the chat, "Let's get data driven" as he begins to state his case.
I hope they can still accrue some data from the past and current trials even though the end points have varied.
Thanks Ed. Good video. Dr. Weber is awesome. He's such a straight shooter. Comment of the chat, "Let's get data driven" as he begins to state his case.
I hope they can still accrue some data from the past and current trials even though the end points have varied.
Thanks Celeste! I've been checking daily since this post. Really like the data on the folks who had to stop ipi-nivo due to adverse effects. Close to a 70 percent response rate–impressive. I didn't have to stop (non trial setting) but I might have had to stop based on trial criteria.
Thanks Celeste! I've been checking daily since this post. Really like the data on the folks who had to stop ipi-nivo due to adverse effects. Close to a 70 percent response rate–impressive. I didn't have to stop (non trial setting) but I might have had to stop based on trial criteria.
Thanks Celeste! I've been checking daily since this post. Really like the data on the folks who had to stop ipi-nivo due to adverse effects. Close to a 70 percent response rate–impressive. I didn't have to stop (non trial setting) but I might have had to stop based on trial criteria.
Viewing 5 reply threads
You must be logged in to reply to this topic.
About the MRF Patient Forum
The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.
The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.
.
.
